In a step toward using stem cells to treat Parkinson’s disease, scientists in South Korea have developed a consistent and efficient way to convert human embryonic stem cells into dopamine-producing nerve cells.
People with Parkinson’s disease have lost the natural dopamine-making cells from one brain region, resulting in the disease’s characteristic symptoms.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.